Literature DB >> 16487689

Two matrix metalloproteinases inhibitors from Ferula persica var. persica.

A R Shahverdi1, F Saadat, M R Khorramizadeh, M Iranshahi, M R Khoshayand.   

Abstract

Matrix metalloproteinases (MMPs) play a role in several physiologic and pathologic events. There is some evidence indicating the involvement of MMPs in tumor invasion and inflammatory diseases. Here we studied the chloroform extract of Ferula persica var. persica. The influence of these extracts vs. a reference drug, diclofenac sodium, on MMP production by the fibrosarcoma cell line was investigated using an in vitro cytotoxicity assay, sodium dodecyl sulfate-polyacrylamide, and gelatin zymography. The total extract of the roots was found to exhibit a selective inhibitory effect on tumor cell invasion. The bioactivity-guided fractionation of this extract led to the isolation of two compounds. These compounds showed highest MMP inhibitory effect at minimal toxic dose levels. Using conventional spectroscopy methods, the active fractions were identified as t-butyl 3-[(1-methylthiopropyl)dithio]-2-propenyl malonate (persicasulphide B) and umbelliprenin, previously isolated from F. persica var. latisecta. Since inhibition of MMP activity has been employed in modality therapy in diseases such as cancer, this compound might be promising in the preparation of anti-MMP therapeutic derivatives.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487689     DOI: 10.1016/j.phymed.2006.01.003

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  19 in total

1.  Hairy root induction and Farnesiferol B production of endemic medicinal plant Ferula pseudalliacea.

Authors:  Abedin Khazaei; Bahman Bahramnejad; Ali-Akbar Mozafari; Dara Dastan; Sima Mohammadi
Journal:  3 Biotech       Date:  2019-10-22       Impact factor: 2.406

2.  Immune-associated proteins with potential in vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approach.

Authors:  Narges Khaghanzadeh; Kazuyuki Nakamura; Yasuhiro Kuramitsu; Abbas Ghaderi; Zahra Mojtahedi
Journal:  Oncol Lett       Date:  2016-11-04       Impact factor: 2.967

3.  Evaluating cytotoxic effect of nanoliposomes encapsulated with umbelliprenin on 4T1 cell line.

Authors:  Mohsen Rashidi; Alireza Ahmadzadeh; Seyed Ali Ziai; Mahsa Narenji; Hamidreza Jamshidi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-09-12       Impact factor: 2.416

4.  Comparative analysis of the cytotoxic effect of 7-prenyloxycoumarin compounds and herniarin on MCF-7 cell line.

Authors:  Seyed Hadi Mousavi; Atiyeh-Sadat Davari; Mehrdad Iranshahi; Sarvenaz Sabouri-Rad; Zahra Tayarani Najaran
Journal:  Avicenna J Phytomed       Date:  2015 Nov-Dec

5.  Types of headache and those remedies in traditional persian medicine.

Authors:  Mohammad M Zarshenas; Peyman Petramfar; Ali Firoozabadi; Mahmood Reza Moein; Abdolali Mohagheghzadeh
Journal:  Pharmacogn Rev       Date:  2013-01

6.  Umbelliprenin Induces Apoptosis in CLL Cell Lines.

Authors:  Seyed Ali Ziai; Omid Gholami; Mehrdad Iranshahi; Amir Hassan Zamani; Mahmood Jeddi-Tehrani
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

7.  Umbelliprenin from Ferula szowitsiana Activates both Intrinsic and Extrinsic Pathways of Apoptosis in Jurkat T-CLL cell line.

Authors:  Omid Gholami; Mahmood Jeddi-Tehrani; Mehrdad Iranshahi; Amir Hassan Zarnani; Seyed Ali Ziai
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 8.  Pharmacological and phytochemical appraisal of selected medicinal plants from jordan with claimed antidiabetic activities.

Authors:  Fatma U Afifi; Violet Kasabri
Journal:  Sci Pharm       Date:  2013-10-15

9.  Cytotoxic activities of phytochemicals from Ferula species.

Authors:  Seied Mojtaba Valiahdi; Mehrdad Iranshahi; Amirhossein Sahebkar
Journal:  Daru       Date:  2013-05-23       Impact factor: 3.117

10.  Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells.

Authors:  Narges Khaghanzadeh; Zahra Mojtahedi; Mohammad Ramezani; Nasrollah Erfani; Abbas Ghaderi
Journal:  Daru       Date:  2012-10-30       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.